French healthcare company makes $1.2bn AI drug discovery deal

18-08-2022

Staff Writer

French healthcare company makes $1.2bn AI drug discovery deal

HJBC / Shutterstock.com

Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.


Sanofi, Atomwise, artificial intelligence, AI, drug discovery, research and development, small-molecule drug candidates

LSIPR